Ouro Medicines Funding: $120M Raised, Series A (2025)
Ouro Medicines is based in San Francisco, California. It has raised $120M in total funding. Latest round: Series A.
Ouro Medicines funding overview
Ouro Medicines is based in San Francisco, California. Ouro Medicines has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Ouro Medicines runs through 2025; nothing later has been disclosed. Investors on record include TPG Life Sciences Innovations, NEA, Norwest Venture Partners, Monograph Capital, GSK, UPMC Enterprises and 2 others. 8 distinct backers are named across the disclosed rounds.
Ouro Medicines has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Ouro Medicines?
TPG Life Sciences Innovations, NEA, Norwest Venture Partners, Monograph Capital, GSK, UPMC Enterprises are named among the investors backing Ouro Medicines.
What was the latest Ouro Medicines funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Ouro Medicines based?
Ouro Medicines is based in San Francisco, California.
When did Ouro Medicines last raise?
The last disclosed Ouro Medicines round closed in January 2025 at Series A.
Every Ouro Medicines figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.
